NDC 0409-2337 – Deferoxamine Mesylate
Deferoxamine Mesylate 2 g/1 · Injection, Powder, Lyophilized, For Solution · Intramuscular, Intravenous, Subcutaneous
Product NDC0409-2337
Product details
- Brand name
- Deferoxamine Mesylate
- Generic name
- Deferoxamine Mesylate
- Labeler
- Hospira, Inc.
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intramuscular, Intravenous, Subcutaneous
- Marketing category
- ANDA · ANDA076019
- Marketed since
- March 31, 2005
- Listing expires
- December 31, 2027
- Pharmacologic class
- Iron Chelator
Active ingredients
- Deferoxamine Mesylate 2 g/1
Uses, dosage, side effects and warnings for Deferoxamine mesylate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0409-2337-25 | 4 VIAL, SINGLE-USE in 1 CARTON (0409-2337-25) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (0409-2337-15) | Mar 31, 2005 |
Other Deferoxamine mesylate products
- 60505-6236 Deferoxamine Mesylate 500 mg/1 · Injection, Powder, Lyophilized, For Solution · Apotex Corp.
- 60505-6237 Deferoxamine Mesylate 2 g/1 · Injection, Powder, Lyophilized, For Solution · Apotex Corp.
- 68083-172 Deferoxamine Mesylate 500 mg/1 · Injection, Powder, Lyophilized, For Solution · Gland Pharma Limited
- 68083-173 Deferoxamine Mesylate 2 g/1 · Injection, Powder, Lyophilized, For Solution · Gland Pharma Limited